Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado, Denver1 site in 1 country50 target enrollmentDecember 4, 2018

ConditionsChronic Pain

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Pain
Sponsor: University of Colorado, Denver
Enrollment: 50
Locations: 1
Primary Endpoint: The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact]
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

A study to help manage chronic pain in cancer survivors through Acceptance and Commitment Therapy (ACT) after undergoing active cancer treatment, such as surgery, chemotherapy, and/or radiation.

Detailed Description

This study attempts to apply effective pain management interventions from other chronic pain populations to those of cancer related populations. It will assess the ability of ACT to alleviate chronic cancer related pain and evaluate ease of implementation of treatment. Patients will be allocated to either the intervention group (ACT) or the control group, getting them the usual course of treatment.

Registry

clinicaltrials.gov

Start Date

December 4, 2018

End Date

March 4, 2021

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

University of Colorado, Denver

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Provision to sign and date the consent form
•Stated willingness to comply with all study procedures and be available for the duration of the study
•Be a male or female aged 18-100
•Have pathology confirmed diagnosis of a solid tumor cancer
•Be three or more months out from active cancer treatment (surgery, chemotherapy, and/or radiation)
•Endorses experiencing pain for three or more months prior to eligibility screening
•Indicates moderate to severe difficulties with pain interference as related to their cancer experience, with a score of 4 or higher on the pain interference item from the Chronic Pain Grading Questionnaire
•Shows no evidence of cancer disease (NED) or with stable, chronic disease under "watchful waiting"
•Fluent in English
•Psychiatric stability as assessed by chart review and study personnel (e.g., not exhibiting symptoms consistent with diagnoses of serious mental illness such as active psychosis or mania)

Exclusion Criteria

•Having pain that can be solely attributed to a diagnosis outside of their cancer experience
•Presenting with barriers to group participation (e.g., social anxiety) or when group-based provision of care would impede participant's treatment or that of other group members
•Patients with a diagnosis of malignant neoplasm of the brain (ICD-10 C71) or malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system (ICD-10 C72).

Outcomes

Primary Outcomes

The Degree of Effectiveness of Acceptance and Commitment Therapy: [Impact]

Time Frame: From baseline to 12 weeks post intervention

Use the Medical Outcomes Study 36-Item Short Form Health Survey to assess emotional wellbeing. Min=0 Max=100 Higher scores indicate better emotional wellbeing.

Secondary Outcomes

The Degree to Which Patients Enjoy Using Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment: [Acceptability](From baseline to end of intervention (weeks 1- 8))
The Ability of Methodological Strategies Used to Monitor and Enhance the Reliability and Validity of ACT: [Fidelity](From baseline to end of intervention (weeks 1- 8))
Number of Participants Who Want to Use Acceptance and Commitment Therapy as a Method for Treating Chronic Pain Post Active Cancer Treatment Active Cancer Treatment(From baseline to end of intervention (weeks 1- 8))